---
title: "Freedom Capital Markets Keeps Their Buy Rating on Clinigence Holdings (NUTX)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300216538.md"
description: "In a report released on September 25, Eugene Mannheimer from Freedom Capital Markets maintained a Buy rating on Clinigence Holdings, with a price target of $306.00. The company’s shares closed last Friday at $220.11. According to TipRanks, Mannheimer is a 4-star analyst with an average return of 7.3% and a 50.00% success rate. Mannheimer covers the Healthcare sector, focusing on stocks such as Omnicell, Irhythm Technologies, and Astrana Health. Currently, the analyst consensus on Clinigence Holdings is a Strong Buy with an average price target of $285.25."
datetime: "2026-09-27T08:55:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300216538.md)
  - [en](https://longbridge.com/en/news/300216538.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300216538.md)
generator: "portal-rs"
---

# Freedom Capital Markets Keeps Their Buy Rating on Clinigence Holdings (NUTX)

In a report released on September 25, Eugene Mannheimer from Freedom Capital Markets maintained a Buy rating on Clinigence Holdings, with a price target of $306.00. The company’s shares closed last Friday at $220.11.

According to TipRanks, Mannheimer is a 4-star analyst with an average return of 7.3% and a 50.00% success rate. Mannheimer covers the Healthcare sector, focusing on stocks such as Omnicell, Irhythm Technologies, and Astrana Health.

Currently, the analyst consensus on Clinigence Holdings is a Strong Buy with an average price target of $285.25.

### Related Stocks

- [NUTX.US](https://longbridge.com/en/quote/NUTX.US.md)
- [OMCL.US](https://longbridge.com/en/quote/OMCL.US.md)
- [IRTC.US](https://longbridge.com/en/quote/IRTC.US.md)
- [ASTH.US](https://longbridge.com/en/quote/ASTH.US.md)

## Related News & Research

- [Freedom Capital Markets maintains Buy rating on Nutex Health, $306 price target](https://longbridge.com/en/news/300143193.md)
- [Nutex Health director Scott J. Saunders sells 203 shares worth $43,492.75](https://longbridge.com/en/news/299479715.md)
- [MU Stock Price Target: Just How Much Room Do Micron Shares Have to Run?](https://longbridge.com/en/news/301599156.md)
- [Phillips 66: Buy Rating Reaffirmed as Strong Refining Margins Support Earnings Outlook; $284 Price Target Maintained](https://longbridge.com/en/news/301569548.md)
- ['Get Ready for What's Next,' Says Top Investor About Micron Stock](https://longbridge.com/en/news/301632208.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**